Nivolumab-Induced Colitis Treated by Infliximab

Clin Gastroenterol Hepatol. 2017 Apr;15(4):e80-e81. doi: 10.1016/j.cgh.2016.09.017. Epub 2016 Sep 21.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents, Immunological / administration & dosage
  • Antineoplastic Agents, Immunological / adverse effects*
  • Colitis / chemically induced*
  • Colitis / drug therapy*
  • Colitis / pathology
  • Colonoscopy
  • Gastrointestinal Agents / administration & dosage*
  • Histocytochemistry
  • Humans
  • Immunologic Factors / administration & dosage*
  • Infliximab / administration & dosage*
  • Male
  • Microscopy
  • Middle Aged
  • Nivolumab / administration & dosage
  • Nivolumab / adverse effects*
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Immunological
  • Gastrointestinal Agents
  • Immunologic Factors
  • Nivolumab
  • Infliximab